|
MAP7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13470000062676E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77790000289014E-08 |
| Normal-vs-Stage2 |
5.183500E-03 |
| Normal-vs-Stage3 |
2.25859997371458E-10 |
| Normal-vs-Stage4 |
6.57209999754826E-08 |
| Stage1-vs-Stage2 |
2.458000E-01 |
| Stage1-vs-Stage3 |
4.270300E-02 |
| Stage1-vs-Stage4 |
9.963500E-02 |
| Stage2-vs-Stage3 |
3.168100E-02 |
| Stage2-vs-Stage4 |
5.234400E-02 |
| Stage3-vs-Stage4 |
8.994600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55509971356116E-10 |
| Normal-vs-AfricanAmerican |
1.799510E-02 |
| Normal-vs-Asian |
3.61609999999235E-06 |
| Caucasian-vs-AfricanAmerican |
1.448220E-01 |
| Caucasian-vs-Asian |
8.874000E-01 |
| AfricanAmerican-vs-Asian |
1.714620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.6853998458829E-10 |
| Normal-vs-Female |
3.33609999625395E-08 |
| Male-vs-Female |
4.159900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62099999978516E-07 |
| Normal-vs-Age(41-60Yrs) |
6.29240000105113E-08 |
| Normal-vs-Age(61-80Yrs) |
7.42619999938299E-08 |
| Normal-vs-Age(81-100Yrs) |
8.153300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.855600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.858800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.599180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.423000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.970760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.358600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.049990E-02 |
| Classical-VS-Follicular |
8.653000E-01 |
| Classical-VS-Other |
4.066400E-01 |
| Classical-VS-Normal |
6.43549999956861E-08 |
| Tall-VS-Follicular |
4.666300E-02 |
| Tall-VS-Other |
8.293200E-01 |
| Tall-VS-Normal |
2.70850000205769E-08 |
| Follicular-VS-Other |
4.869400E-01 |
| Follicular-VS-Normal |
2.11169999999594E-05 |
| Other-VS-Normal |
9.540500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22279999961827E-07 |
| Normal-vs-N1 |
5.27489999457842E-08 |
| N0-vs-N1 |
1.109790E-01 |
|
|
